There have been several new developments in the field of hematology and oncology. There is a need for educational sessions for healthcare providers involved in management of hematologic malignancies and solid tumors.
At the conclusion of this activity, participants will be able to:
a) Recognize factors that affect the diagnosis, staging, and prognosis of patients with hematologic malignancies and solid tumors
b) Explain indications and contraindications of treatments used for hematologic malignancies and lung cancers, breast cancers, and colon cancers
c) Discuss emerging therapeutic options for treating patients with hematologic malignancies and solid tumors with colleagues and patients
d) Interpret and practice relevant data presented at ASCO 2014 meeting
e) Nurses will be able to provide appropriate care and counsel to patients and families with lung cancer, colon cancer, breast cancer, and hematologic malignancies